Page last updated: 2024-12-07

rhodamine 800

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rhodamine 800: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127750
SCHEMBL ID7686298
MeSH IDM0275687

Synonyms (20)

Synonym
rhodamine 800
SCHEMBL7686298 ,
101027-54-7
AKOS015898263
137993-41-0
DTXSID80143686
J-000312
rhodamine 800, suitable for fluorescence
9-cyano-2,3,6,7,12,13,16,17-octahydro-1h,5h,11h,15h-xantheno[2,3,4-ij:5,6,7-i/'j/']diquinolizin-18-i
CS-8101
HY-101876
mfcd00467020
R0190
3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaene-16-carbonitrile;perchlorate
1h,5h,11h,15h-xantheno[2,3,4-ij:5,6,7-i'j']diquinolizin-18-ium, 9-cyano-2,3,6,7,12,13,16,17-octahydro-, perchlorate (1:1)
rhodamine800
AS-78050
PD102688
E85434
AKOS040744112
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's3 (23.08)29.6817
2010's6 (46.15)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.65 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]